486 related articles for article (PubMed ID: 15539405)
1. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
[TBL] [Abstract][Full Text] [Related]
2. Metastatic growth of lung cancer cells is extremely reduced in Vitamin D receptor knockout mice.
Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):545-7. PubMed ID: 15225835
[TBL] [Abstract][Full Text] [Related]
3. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.
Nakagawa K; Sasaki Y; Kato S; Kubodera N; Okano T
Carcinogenesis; 2005 Jun; 26(6):1044-54. PubMed ID: 15718253
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
Healy KD; Frahm MA; DeLuca HF
Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
[TBL] [Abstract][Full Text] [Related]
5. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
[TBL] [Abstract][Full Text] [Related]
8. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors.
Zinser GM; Tribble E; Valrance M; Urben CM; Knutson JC; Mazess RB; Strugnell SA; Welsh J
Anticancer Res; 2005; 25(1A):235-41. PubMed ID: 15816543
[TBL] [Abstract][Full Text] [Related]
9. MAPK inhibition by 1alpha,25(OH)2-Vitamin D3 in breast cancer cells. Evidence on the participation of the VDR and Src.
Rossi AM; Capiati DA; Picotto G; Benassati S; Boland RL
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):287-90. PubMed ID: 15225787
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
[TBL] [Abstract][Full Text] [Related]
11. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice.
Mathieu C; Van Etten E; Gysemans C; Decallonne B; Kato S; Laureys J; Depovere J; Valckx D; Verstuyf A; Bouillon R
J Bone Miner Res; 2001 Nov; 16(11):2057-65. PubMed ID: 11697802
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M; Makishima M
Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
[TBL] [Abstract][Full Text] [Related]
15. Regulation of growth plate chondrocytes by 1,25-dihydroxyvitamin D3 requires caveolae and caveolin-1.
Boyan BD; Wong KL; Wang L; Yao H; Guldberg RE; Drab M; Jo H; Schwartz Z
J Bone Miner Res; 2006 Oct; 21(10):1637-47. PubMed ID: 16995819
[TBL] [Abstract][Full Text] [Related]
16. Regulation of gene expression of epithelial calcium channels in intestine and kidney of mice by 1alpha,25-dihydroxyvitamin D3.
Okano T; Tsugawa N; Morishita A; Kato S
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):335-8. PubMed ID: 15225796
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G
J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775
[TBL] [Abstract][Full Text] [Related]
18. VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3.
Baroni E; Biffi M; Benigni F; Monno A; Carlucci D; Carmeliet G; Bouillon R; D'Ambrosio D
J Leukoc Biol; 2007 Jan; 81(1):250-62. PubMed ID: 17035339
[TBL] [Abstract][Full Text] [Related]
19. TRPC3-like protein and vitamin D receptor mediate 1alpha,25(OH)2D3-induced SOC influx in muscle cells.
Santillán G; Katz S; Vazquez G; Boland RL
Int J Biochem Cell Biol; 2004 Oct; 36(10):1910-8. PubMed ID: 15203106
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
